![](/img/cover-not-exists.png)
Phase II study of avelumab in multiple relapsed/refractory germ cell cancer
Mego, M., Svetlovska, D., Chovanec, M., Rečkova, M., Rejlekova, K., Obertova, J., Palacka, P., Sycova-Mila, Z., De Giorgi, U., Mardiak, J.Language:
english
Journal:
Investigational New Drugs
DOI:
10.1007/s10637-019-00805-4
Date:
June, 2019
File:
PDF, 345 KB
english, 2019